From: An immunoassay that distinguishes real neuromyelitis optica signals from a labeling detected in patients receiving natalizumab
Gene
Primer sequences
hAQP4-M23
Forward : 5′-ACTCCTCGAGGGCGGTGGGGTAAGTGTGGAC -3′
Reverse: 5′-ACTCCCCGGGAATGGGTGGAAGGAAATCTGA -3′